A study conducted by Kang et al. [26] showed impaired NKT cell activity in the RIPK3 deletion mice, drawing the conclusion that RIPK3 was involved in the regulation and promotion of NKT cell-mediated anti-tumor immunity. The gene discussed is RIPK3; the disease is neoplasm.